Digestives & Intestinal Remedies - Denmark

  • Denmark
  • In Denmark, the Digestives & Intestinal Remedies market market generated a revenue of US$4.06m in 2024.
  • It is projected to experience an annual growth rate of 1.90% (CAGR 2024-2029).
  • When compared to other countries worldwide, in China leads the market with a revenue of US$4,408.00m in 2024.
  • In terms of per capita figures, the revenue generated per person in Denmark amounted to US$0.68 in 2024.
  • Denmark's strong focus on natural and organic products is driving a growing demand for digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Denmark is experiencing steady growth driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in Denmark are shifting towards natural and organic products, including those for digestive health. Consumers are becoming increasingly health-conscious and are seeking products that are free from artificial ingredients and chemicals. This preference for natural remedies is driving the demand for digestive and intestinal remedies made from herbal and plant-based ingredients. Additionally, consumers are also looking for products that are easy to consume and convenient to use, such as chewable tablets or capsules.Trends in the market indicate a growing awareness of the importance of digestive health in Denmark. With the rise in sedentary lifestyles and unhealthy eating habits, digestive issues such as bloating, indigestion, and constipation have become common problems. As a result, there is a growing demand for products that can alleviate these symptoms and promote overall digestive health. This has led to an increase in the availability of digestive and intestinal remedies in the market, both in physical stores and online platforms.Local special circumstances in Denmark, such as the high level of disposable income and the well-developed healthcare system, contribute to the growth of the Digestives & Intestinal Remedies market. The high disposable income allows consumers to afford premium and higher-priced products that are often associated with better quality and efficacy. Additionally, the well-developed healthcare system in Denmark ensures easy access to healthcare professionals who can recommend and prescribe digestive and intestinal remedies to patients.Underlying macroeconomic factors, such as the aging population and increasing healthcare expenditure, also play a role in the growth of the market. The aging population in Denmark is more prone to digestive issues and is therefore more likely to seek remedies to alleviate their symptoms. Moreover, the increasing healthcare expenditure in the country indicates a greater focus on preventive healthcare and self-care, leading to higher demand for digestive and intestinal remedies.In conclusion, the Digestives & Intestinal Remedies market in Denmark is growing due to customer preferences for natural and organic products, the increasing awareness of digestive health, local special circumstances such as high disposable income and a well-developed healthcare system, and underlying macroeconomic factors like the aging population and increasing healthcare expenditure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)